Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 4/20 | 0.68 |
| ▸ | ZDHHC2 | Q9UIJ5 | 2/20 | 0.68 |
| ▸ | MGLL | Q99685 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA9 | Q16790 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | THRA | P10827 | 5/20 | 0.40 |
| ▸ | THRB | P10828 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP3 | P08254 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15233346 | 1.00 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2MGLLCA12CA1 | |
| SCHEMBL6117112 | 1.00 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2MGLLCA12CA1 | |
| SCHEMBL26598588 | 1.00 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2MGLLCA12CA1 | |
| SCHEMBL6514883 | 1.00 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2MGLLCA12CA1 | |
| SCHEMBL6117478 | 1.00 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2MGLLCA12CA1 | |
| SCHEMBL6117891 | 1.00 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2MGLLCA12CA1 | |
| SCHEMBL12200654 | 1.00 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2MGLLCA12CA1 | |
| SCHEMBL15233345 | 0.98 | ZDHHC20 (0.65) | ZDHHC20ZDHHC2MGLLCA12CA1 | |
| SCHEMBL16776745 | 0.94 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2MGLLCA12CA1 | |
| SCHEMBL16776752 | 0.94 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2MGLLCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024008241-A1 | REFERENCE MATERIAL FOR SOLID-STATE ANALYTICS, METHOD FOR PRODUCING THE REFERENCE MATERIAL, AND USE OF THE REFERENCE MATERIAL | TECHNISCHE UNIVERSITÄT BERGAKADEMIE FREIBERG (DE) | 2024-01-11 | — | — | WO | claimed |
| EP-1400538-A1 | Method of producing synthetic polymer gel | L'OREAL (FR) | 2004-03-24 | — | — | EP | claimed |
| US-20250101241-A1 | ACTIVE ENERGY RAY CURABLE COMPOSITION | KJ CHEMICALS CORPORATION (JP) | 2025-03-27 | — | — | US | disclosed |
| EP-4435021-A1 | ACTIVE ENERGY RAY-CURABLE COMPOSITION | KJ Chemicals Corporation (JP) | 2024-09-25 | — | — | EP | disclosed |
| WO-2024008241-A1 | REFERENCE MATERIAL FOR SOLID-STATE ANALYTICS, METHOD FOR PRODUCING THE REFERENCE MATERIAL, AND USE OF THE REFERENCE MATERIAL | TECHNISCHE UNIVERSITÄT BERGAKADEMIE FREIBERG (DE) | 2024-01-11 | — | — | WO | disclosed |
| WO-2023109751-A1 | PYRIMIDINE OR PYRIDINE DERIVATIVE AND MEDICINAL USE THEREOF | 希格生科（深圳）有限公司 | 2023-06-22 | — | — | WO | disclosed |
| WO-2023090302-A1 | ACTIVE ENERGY RAY-CURABLE COMPOSITION | ＫＪケミカルズ株式会社 | 2023-05-25 | — | — | WO | disclosed |
| CN-111094444-B | Aqueous polymer composition | 陶氏环球技术有限责任公司 | 2022-06-03 | — | — | CN | disclosed |
| US-9763957-B2 | Autotaxin inhibitors | NOVARTIS AG (CH) | 2017-09-19 | — | — | US | disclosed |
| US-20160184318-A1 | AUTOTAXIN INHIBITORS | NOVARTIS AG (CH) | 2016-06-30 | — | — | US | disclosed |
| US-20140350205-A1 | NOVEL SHEAR-RESISTANT POLYMER SYSTEMS, PRODUCTION THEREOF, AND ALSO USE THEREOF AS THICKENERS | POLYPREC GMBH (DE) | 2014-11-27 | — | — | US | disclosed |
| EP-0737896-B1 | Photosensitive composition and photosensitive planographic printing plate | KODAK POLYCHROME GRAPHICS JP (JP) | 2003-08-27 | — | — | EP | disclosed |
| US-6489422-B2 | HAIR CLEANING COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-03 | — | — | US | disclosed |
| EP-1050565-A2 | Method of hydrophobisation and preparations for carrying out said method | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-08 | — | — | EP | disclosed |
| CN-1250647-A | Thickening agent used for compositions contg. surfactant | BASF AG (DE) | 2000-04-19 | — | — | CN | disclosed |
| CN-1231299-A | Use of copolymers of monoethylenically unsaturated carboxylic acids as solubilizers | BASF AG (DE) | 1999-10-13 | — | — | CN | disclosed |
| EP-0394923-B1 | Photosensitive lithographic printing plate requiring no wetting water | KONISHIROKU PHOTO IND (JP) | 1996-07-03 | — | — | EP | disclosed |
| EP-0394924-B1 | Photosensitive lithographic printing plate requiring no wetting water | MITSUBISHI CHEM CORP (JP) | 1995-07-12 | — | — | EP | disclosed |
| EP-0394923-A2 | Photosensitive lithographic printing plate requiring no wetting water | KONICA CORPORATION (JP) | 1990-10-31 | — | — | EP | disclosed |
| EP-0394924-A2 | Photosensitive lithographic printing plate requiring no wetting water | Mitsubishi Chemical Corporation (JP) | 1990-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160184318-A1 | AUTOTAXIN INHIBITORS | ENPP2, SERPINB1, TFPI | ZDHHC20 977/4885ZDHHC2 3146/4885MGLL 2134/4885 |
| US-20250101241-A1 | ACTIVE ENERGY RAY CURABLE COMPOSITION | PARP1, CAP1, XRN2 | ZDHHC20 3567/4885ZDHHC2 3784/4885MGLL 2427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.